AB
ABBV icon

AT Bancorp’s AbbVie ABBV Stock Holding History

AT Bancorp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.1M Sell
26,088
-344
-1% -$28.1K 0.26% 42
2018
Q4 		$2.44M Buy
26,432
+300
+1% +$26.4K 0.32% 38
2018
Q3 		$2.47M Hold
26,132
– – 0.27% 52
2018
Q2 		$2.42M Sell
26,132
-700
-3% -$68.4K 0.27% 47
2018
Q1 		$2.54M Buy
26,832
+700
+3% +$76.9K 0.27% 45
2017
Q4 		$2.53M Sell
26,132
-190
-0.7% -$17.9K 0.27% 47
2017
Q3 		$2.34M Buy
26,322
+100
+0.4% +$7.61K 0.27% 43
2017
Q2 		$1.9M Sell
26,222
-70
-0.3% -$4.71K 0.22% 54
2017
Q1 		$1.71M Buy
26,292
+295
+1% +$18.5K 0.22% 80
2016
Q4 		$1.63M Sell
25,997
-803
-3% -$49K 0.22% 80
2016
Q3 		$1.69M Hold
26,800
– – 0.23% 91
2016
Q2 		$1.66M Sell
26,800
-200
-0.7% -$12.2K 0.25% 105
2016
Q1 		$1.54M Buy
27,000
+94
+0.3% +$5.24K 0.23% 112
2015
Q4 		$1.59M Sell
26,906
-438
-2% -$25.2K 0.44% 73
2015
Q3 		$1.49M Hold
27,344
– – 0.43% 77
2015
Q2 		$1.84M Sell
27,344
-26
-0.1% -$1.7K 0.47% 71
2015
Q1 		$1.6M Hold
27,370
– – 0.44% 83
2014
Q4 		$1.79M Buy
27,370
+56
+0.2% +$3.53K 0.53% 69
2014
Q3 		$1.58M Buy
27,314
+441
+2% +$24.5K 0.46% 78
2014
Q2 		$1.52M Sell
26,873
-46,151
-63% -$2.42M 0.45% 77
2014
Q1 		$3.75M Buy
73,024
+46,219
+172% +$2.34M 1.16% 22
2013
Q4 		$1.42M Sell
26,805
-910
-3% -$44.7K 0.43% 71
2013
Q3 		$1.24M Buy
27,715
+696
+3% +$30.9K 0.44% 69
2013
Q2 		$1.12M Buy
+27,019
New +$1.18M 0.41% 84

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AT Bancorp's ABBV Position: Q1 2019 in Review

AT Bancorp reduced its AbbVie (ABBV) stake by 1.3% in Q1 2019, selling an estimated $28.1K and leaving 26,088 shares worth $2.1M. The position accounts for 0.26% of the portfolio, ranked #42.

AT Bancorp first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $3.75M in Q1 2014. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • AT Bancorp held 26,088 shares of AbbVie worth $2.1M as of Q1 2019.
  • AT Bancorp sold 344 AbbVie shares in Q1 2019, an estimated $28.1K.
  • AbbVie made up 0.26% of AT Bancorp's portfolio in Q1 2019, its #42 holding.
  • AT Bancorp first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
  • AT Bancorp's AbbVie position peaked at $3.75M in Q1 2014.
  • 2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.